Page last updated: 2024-09-05

lenalidomide and sgi 1776

lenalidomide has been researched along with sgi 1776 in 2 studies

Compound Research Comparison

Studies
(lenalidomide)
Trials
(lenalidomide)
Recent Studies (post-2010)
(lenalidomide)
Studies
(sgi 1776)
Trials
(sgi 1776)
Recent Studies (post-2010) (sgi 1776)
3,5327252,85059056

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)sgi 1776 (IC50)
Tyrosine-protein kinase YesHomo sapiens (human)1.455
Serine/threonine-protein kinase pim-1Homo sapiens (human)0.0158
Delta-type opioid receptorRattus norvegicus (Norway rat)0.007
Mu-type opioid receptorRattus norvegicus (Norway rat)0.362
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.0382
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.069
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.8727
Serine/threonine-protein kinase pim-3Homo sapiens (human)0.0659
Serine/threonine-protein kinase haspinHomo sapiens (human)0.034
Serine/threonine-protein kinase pim-2Homo sapiens (human)0.4053

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Chao, N; Ebens, A; Foreman, O; Gasparetto, C; Hu, J; Kang, Y; Kozlowski, C; Lazarchick, J; Roof, L; Sha, Y; Venkta, JK; Zheng, J1

Other Studies

2 other study(ies) available for lenalidomide and sgi 1776

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade.
    Cancer letters, 2019, Volume: 440-441

    Topics: Adaptor Proteins, Signal Transducing; Animals; Down-Regulation; Humans; Ikaros Transcription Factor; Imidazoles; Lenalidomide; Mice; Mice, Inbred C57BL; Multiple Myeloma; Peptide Hydrolases; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Pyridazines; Signal Transduction; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays

2019